Ann Arbor, Michigan

The University of Michigan Comprehensive Cancer Center (UMCCC) was founded in 1986. UMCCC received its NCI designation as a cancer center in 1988 and its comprehensive designation in 1991. The Center is also a founding member of the National Comprehensive Cancer Network. As part of the University of Michigan Health System, UMCCC brings together in one place more than 400 scientists and clinicians in multidisciplinary teams devoted to cancer research and patient care.

UMCCC’s mission is the conquest of cancer through innovation and collaboration. The center has 13 basic, clinical/translational, and cancer prevention and control programs. Laboratory research is conducted in six basic research programs: cancer cell biology, cancer genetics, molecular imaging, molecular therapeutics, radiation sciences, and tumor immunology and host response.

Clinical research programs include breast oncology, prostate oncology, head and neck oncology, gastrointestinal oncology, and leukemia/lymphoma-blood and marrow transplantation. There are developing programs in thoracic oncology, connective tissue, childhood cancers, neuro-oncology, endocrine oncology, and psycho-oncology.

The Ravitz Foundation Phase 1/Translational Research Center at UMCCC focuses on promising molecular therapeutics, moving basic science discoveries into human clinical trials. The program’s early stage clinical trials help speed promising new therapies to cancer patients, with an emphasis on targeted agents.

Research on cancer prevention and control is divided into biomedical prevention and socio-behavioral research. In addition, UMCCC has a strong focus on outcomes and disparities research. The Center draws members from the University of Michigan Schools of Public Health, Nursing, Social Work and Information who are engaged in these areas of research.

UMCCC offers multidisciplinary clinics in 14 different cancer types. In each of these clinics, specialized physicians, including dedicated pathologists and radiologists, collaborate to provide comprehensive care for each patient. Michigan’s teams of physicians and nurses work with colleagues in local communities to provide ongoing care for cancer patients and their families. Risk evaluations, genetic counseling, and fertility counseling are also provided.

The Center’s Survivorship program includes research that will help define the future of survivorship care and clinical care designed to assist patients making the transition from cancer care to long-term survivorship. The program is part of a comprehensive Patient and Family Support Services program that offers more than 30 different services, including psycho-oncology, complementary therapies, nutrition services, symptom management, and a grief and loss program.